207 related articles for article (PubMed ID: 29034063)
1. Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles.
Peng C; Gao X; Xu J; Du B; Ning X; Tang S; Bachoo RM; Yu M; Ge WP; Zheng J
Nano Res; 2017 Apr; 10(4):1366-1376. PubMed ID: 29034063
[TBL] [Abstract][Full Text] [Related]
2. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.
Liu J; Yu M; Zhou C; Yang S; Ning X; Zheng J
J Am Chem Soc; 2013 Apr; 135(13):4978-81. PubMed ID: 23506476
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide,
Georgiou CJ; Cai Z; Alsaden N; Cho H; Behboudi M; Winnik MA; Rutka JT; Reilly RM
Mol Pharm; 2023 Jan; 20(1):582-592. PubMed ID: 36516432
[TBL] [Abstract][Full Text] [Related]
4. Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects.
Yu M; Zhou C; Liu L; Zhang S; Sun S; Hankins JD; Sun X; Zheng J
Angew Chem Int Ed Engl; 2017 Apr; 56(15):4314-4319. PubMed ID: 28295960
[TBL] [Abstract][Full Text] [Related]
5. Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles.
Peng C; Xu J; Yu M; Ning X; Huang Y; Du B; Hernandez E; Kapur P; Hsieh JT; Zheng J
Angew Chem Int Ed Engl; 2019 Jun; 58(25):8479-8483. PubMed ID: 31006932
[TBL] [Abstract][Full Text] [Related]
6. Surface-regulated injection dose response of ultrasmall luminescent gold nanoparticles.
Zhu J; Zhao Z; Chen H; Chen X; Liu J
Nanoscale; 2022 Jun; 14(24):8818-8824. PubMed ID: 35686670
[TBL] [Abstract][Full Text] [Related]
7. Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior.
Liu X; Chen Y; Li H; Huang N; Jin Q; Ren K; Ji J
ACS Nano; 2013 Jul; 7(7):6244-57. PubMed ID: 23799860
[TBL] [Abstract][Full Text] [Related]
8. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles.
Xu Y; Wu H; Huang J; Qian W; Martinson DE; Ji B; Li Y; Wang YA; Yang L; Mao H
Theranostics; 2020; 10(6):2479-2494. PubMed ID: 32194814
[No Abstract] [Full Text] [Related]
9. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
[TBL] [Abstract][Full Text] [Related]
10. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.
Liu X; Li H; Chen Y; Jin Q; Ren K; Ji J
Adv Healthc Mater; 2014 Sep; 3(9):1439-47. PubMed ID: 24550205
[TBL] [Abstract][Full Text] [Related]
11. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
Kang JH; Cho J; Ko YT
J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Ruan S; He Q; Gao H
Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
[TBL] [Abstract][Full Text] [Related]
13. In Vivo X-ray Imaging of Transport of Renal Clearable Gold Nanoparticles in the Kidneys.
Xu J; Yu M; Carter P; Hernandez E; Dang A; Kapur P; Hsieh JT; Zheng J
Angew Chem Int Ed Engl; 2017 Oct; 56(43):13356-13360. PubMed ID: 28881491
[TBL] [Abstract][Full Text] [Related]
14. Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery.
Smilowitz HM; Meyers A; Rahman K; Dyment NA; Sasso D; Xue C; Oliver DL; Lichtler A; Deng X; Ridwan SM; Tarmu LJ; Wu Q; Salner AL; Bulsara KR; Slatkin DN; Hainfeld JF
Int J Nanomedicine; 2018; 13():3937-3948. PubMed ID: 30013346
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.
Ding Y; Sun Z; Tong Z; Zhang S; Min J; Xu Q; Zhou L; Mao Z; Xia H; Wang W
Theranostics; 2020; 10(12):5195-5208. PubMed ID: 32373207
[TBL] [Abstract][Full Text] [Related]
16. iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.
Yang Y; Chen Q; Li S; Ma W; Yao G; Ren F; Cai Z; Zhao P; Liao G; Xiong J; Yu Z
J Biomed Nanotechnol; 2018 Aug; 14(8):1396-1408. PubMed ID: 29903055
[TBL] [Abstract][Full Text] [Related]
17. Passive targeting of high-grade gliomas
Caro C; Avasthi A; Paez-Muñoz JM; Pernia Leal M; García-Martín ML
Biomater Sci; 2021 Nov; 9(23):7984-7995. PubMed ID: 34710207
[TBL] [Abstract][Full Text] [Related]
18. Lung retention and particokinetics of silver and gold nanoparticles in rats following subacute inhalation co-exposure.
Kim JK; Kim HP; Park JD; Ahn K; Kim WY; Gulumian M; Oberdörster G; Yu IJ
Part Fibre Toxicol; 2021 Jan; 18(1):5. PubMed ID: 33478543
[TBL] [Abstract][Full Text] [Related]
19. Correlating Anticancer Drug Delivery Efficiency with Vascular Permeability of Renal Clearable Versus Non-renal Clearable Nanocarriers.
Peng C; Yu M; Hsieh JT; Kapur P; Zheng J
Angew Chem Int Ed Engl; 2019 Aug; 58(35):12076-12080. PubMed ID: 31278873
[TBL] [Abstract][Full Text] [Related]
20. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
